HOOKIPA Pharma Presents Additional Preliminary Phase 2 Data
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line...
Source: globenewswire.com
Stay updated with breaking news from Positive Head. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
42 percent objective response rate (ORR) was observed among 19 evaluable patients with recurrent/metastatic head and neck cancer in the first-line...
VTV.vn - Với PTL Lựa chọn của tôi, khán giả sẽ được lắng nghe câu chuyện của những tình nguyện viên - những người bất chấp nguy cơ lây nhiễm COVID-19 đi...